A Structured Analytical Framework for Assessing Clinical Research and Implementation Priorities of Caffeine Citrate Therapy in Neonatal Care across Sub-Saharan Africa
Keywords:
Caffeine citrate, neonatal care, apnea of prematurity, Sub-Saharan Africa, clinical researchAbstract
Caffeine citrate has emerged as a cornerstone pharmacological intervention for apnea of prematurity, demonstrating substantial benefits in reducing respiratory morbidity and improving neurodevelopmental outcomes among preterm infants. Despite strong clinical evidence supporting its efficacy and cost-effectiveness, its implementation across Sub-Saharan Africa remains inconsistent and limited. This study develops a structured analytical framework to systematically assess clinical research gaps and implementation priorities associated with caffeine citrate therapy in neonatal care settings across the region.
The study adopts a survey-research-informed analytical model integrating evidence synthesis, contextual health system evaluation, and implementation feasibility metrics. The framework draws upon existing literature to evaluate therapeutic efficacy, accessibility barriers, economic implications, and research deficiencies. Particular emphasis is placed on methodological rigor, including the importance of randomized controlled trials as the gold standard for intervention validation (Hariton & Locascio, 2018).
Findings indicate that while caffeine therapy is clinically effective and economically viable, systemic challenges—including supply chain limitations, lack of standardized protocols, and insufficient clinical research infrastructure—significantly hinder its widespread adoption. The study highlights critical research gaps in context-specific clinical trials and implementation science.
The proposed framework provides a structured tool for policymakers, clinicians, and researchers to prioritize interventions, optimize neonatal care strategies, and guide future research in low-resource settings. The study concludes that bridging the gap between clinical evidence and practical implementation is essential to improving neonatal outcomes in Sub-Saharan Africa.
Downloads
References
1. Abdel-Hady H, Nasef N, Shabaan AE, Nour I. Caffeine therapy in preterm infants. World J Clin Pediatr.2015;4(4):81-93.
2. Amponsah SK, Nartey CM, Ofori EK. The Use of Caffeine Citrate in the Management of Neonatal Apnea in Low‐and Middle‐Income Countries: A
3. Bhutta ZA, Salam RA, Lassi ZS, et al. Approaches to improve quality of care (QoC) for women and newborns: conclusions, evidence gaps and research priorities. Reprod Health.2014;11(suppl 2):S5.
4. Dukhovny D, Lorch SA, Schmidt B, Doyle LW, Kok JH, Roberts RS, Kamholz KL, Wang N, Mao W, Zupancic JA; Caffeine for Apnea of Prematurity Trial Group. Economic evaluation of caffeine for apnea of prematurity. Pediatrics.2011;127(1):e146-e155.
5. Ekhaguere OA, Bolaji O, Nabwera HM, Storey A, Embleton N, Allen S, et al. A landscape evaluation of caffeine citrate availability and use in newborn care across five low-and middle-income countries. PLoS Glob Public Health.2024;4(7):e0002486.
6. Ekhaguere OA, Ayede AI, Ezeaka CV. Is caffeine available and affordable in low-and middle-income countries? A survey in sub-Saharan Africa. Semin Fetal Neonatal Med.2020;25(6):101182.
7. Fleming, J., & Zegwaard, K. E. (2018). Methodologies, methods and ethical considerationsfor conducting research in work-integrated learning. International Journal of Work-Integrated Learning, 19(3), 205-213.
8. G G, Deorari A. Study designs. J Neonatol.2005;19(1):60-65.
9. Harrison L, Vaivada T, Yasin R, Das JK, Bhutta ZA. Rationale and approach to evaluating interventionsfor newborn care in low-and middle-income countries. Neonatology.2025;122(suppl 1):5-12.
10. Hariton E, Locascio JJ. Randomised controlled trials—the gold standard for effectiveness research: study design: randomised controlled trials. BJOG.2018;125(13):1716.
11. Kumar R, Khosla R, McCoy D. Decolonising global health research: shifting power for transformative change. PLoS Glob Public Health.2024;4(4):e0003141.
12. Makwana D, Engineer P, Dabhi A, Chudasama H. Sampling methods in research: a review. 2023; 7:762-768.
13. Miao Y, Zhou Y, Zhao S, Liu W, Wang A, Zhang Y, et al.Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: a systematic review and meta-analysis. PLoS One.2022;17(9):e0274882.
14. Moschino L, Zivanovic S, Hartley C, Trevisanuto D, Baraldi E, Roehr CC. Caffeine in preterm infants: where are we in 2020? ERJ Open Res.2020;6(1):00330-2019.
15. Nabwera HM, Ekhaguere OA, Kirpalani H, Burgoine K, Ezeaka CV, Otieno W, et al. Caffeine for the care of preterm infants in sub-Saharan Africa: a missed opportunity? BMJ Glob Health.2021;6(12):e007682.
16. Nabwera HM, Wang D, Tongo OO, Andang’o PEA, Abdulkadir I, Ezeaka CV, et al. Burden of disease and risk factors for mortality amongst hospitalized newborns in Nigeria and Kenya. PLoS One.2021;16(1):e0244109.
17. Ohuma EO, Moller AB, Bradley E, Chakwera S, Hussain-Alkhateeb L, Lewin A, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet.2023;402(10409):1261-1271.
18. Oliphant EA, Hanning SM, McKinlay CJD, et al. Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis. J Perinatol.2024;44:785-801.
19. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med.2006;354(20):2112-2121.
20. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med.2007;357(19):1893-1902.
21. Taylor-Robinson SD, Spearman CW, Suliman AAA. Why is there a paucity of clinical trials in Africa? QJM.2021;114(6):357-358.
22. World Health Organization. WHO recommendationsfor care of the preterm or low-birth-weight infant.World Health Organization; 2022. Accessed October 26, 2025. https://reliefweb.int/report/world/who-recommendations-care-preterm-or-low-birth-weight-infant.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Arya Wibawa, Ms. Rani Oktaviani (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published by The Parthenon Frontiers and its associated journals are distributed under the terms of the Creative Commons Attribution (CC BY 4.0) International License unless otherwise stated.
Authors retain full copyright of their published work. By submitting their manuscript, authors agree to grant The Parthenon Frontiers a non-exclusive license to publish, archive, and distribute the article worldwide. Authors are free to:
-
Share their article on personal websites, institutional repositories, or social media platforms.
-
Reuse their content in future works, presentations, or educational materials, provided proper citation of the original publication.
